Recombinant Human TWIST2 Protein, N-His-SUMO & C-Strep

Description of Recombinant Human TWIST2 Protein, N-His-SUMO & C-Strep

Structure of Recombinant Human TWIST2 Protein

Recombinant human TWIST2 protein, also known as Twist-related protein 2, is a member of the basic helix-loop-helix (bHLH) family of transcription factors. It is encoded by the TWIST2 gene located on chromosome 2 in humans. The protein consists of 202 amino acids and has a molecular weight of approximately 22 kDa.

The structure of TWIST2 protein consists of two distinct domains: the basic region and the helix-loop-helix (HLH) region. The basic region contains a DNA binding motif, while the HLH region is responsible for protein-protein interactions. These domains play a crucial role in the function of TWIST2 protein as a transcription factor.

Activity of Recombinant Human TWIST2 Protein

TWIST2 protein is involved in various cellular processes, including embryonic development, cell differentiation, and cell migration. It has been shown to regulate the expression of genes involved in epithelial-mesenchymal transition (EMT), a process that plays a critical role in tumor metastasis. TWIST2 is also involved in the regulation of cell proliferation and apoptosis, making it a key player in cancer development and progression.

As a transcription factor, TWIST2 binds to specific DNA sequences, known as E-boxes, and regulates the expression of target genes. It can act as both a transcriptional activator and a repressor, depending on the cellular context and the presence of other co-regulators. TWIST2 is known to interact with other transcription factors, such as Snail, Slug, and ZEB1, to regulate gene expression and control cellular processes.

Application of Recombinant Human TWIST2 Protein

The recombinant human TWIST2 protein has been widely used in various research studies to understand its role in cancer and other diseases. It is commonly expressed in E. coli or mammalian cells and purified to high levels for in vitro experiments. The protein has also been used to generate specific antibodies for detection and quantification of TWIST2 in various tissues and cell lines.

One of the major applications of recombinant human TWIST2 protein is in cancer research. Studies have shown that TWIST2 is overexpressed in several types of cancer, including breast, lung, and colon cancer. It has been linked to tumor growth, invasion, and metastasis, making it a potential therapeutic target for cancer treatment. Recombinant TWIST2 protein has been used in cell-based assays to investigate its role in cancer development and to screen for potential inhibitors that can block its activity.

In addition to cancer, TWIST2 has also been implicated in other diseases, such as cardiovascular disorders, fibrosis, and neurodegenerative diseases. The recombinant protein has been used to study its role in these conditions and to identify potential therapeutic strategies.

Conclusion

In summary, recombinant human TWIST2 protein is a crucial transcription factor involved in various cellular processes, including cancer development and progression. Its structure, activity, and application have been extensively studied, and it continues to be a subject of interest in the scientific community. With further research, TWIST2 protein may hold the key to understanding and treating various diseases.